Stanniocalcin 1 and stanniocalcin 2 are two glycoprotein hormones, which act as calcium phosphate-regulating factor on intestine and kidney. We have previously reported that stanniocalcin 2 expression is positively and negatively controlled by 1,25(OH)2D3 and parathyroid hormone in renal proximal tubular cells. However, it has been unclear whether they regulate the stanniocalcin 1 gene expression. In this study, we identified the opossum stanniocalcin 1 cDNA sequence. The opossum stanniocalcin 1 amino acid sequence had 83% homology with human stanniocalcin 1, and has a conserved putative N-linked glycosylation site. Real-time PCR analysis using opossum kidney proximal tubular (OK-P) cells revealed that the mRNA levels of stanniocalcin 1 gene is upregulated by both 1,25(OH)2D3 and parathyroid hormone in dosedependent and time-dependent manners. We also demonstrated that the stanniocalcin 1 expression was increased in parathyroid hormone injected rat kidney. Furthermore, the mRNA expression of stanniocalcin 1 and stanniocalcin 2 were oppositely regulated by phorbol 12,13-myristic acetate, a specific PKC activator. Interestingly, the up-regulation of stanniocalcin 1 gene by 1,25(OH)2D3 and phorbol 12,13-myristic acetate were not prevented in the presence of actinomycin D, an RNA synthesis inhibitor. These results suggest that the stanniocalcin 1 gene expression is upregulated by 1,25(OH)2D3 and parathyroid hormone through mRNA stabilization in renal proximal tubular cells.
Introduction S tanniocalcin (STC) is a glycoprotein hormone first identified from the corpuscles of Stannius in bony fish, endocrine glands that are embryologically derived from the kidney tubules. (1, 2) An increase in plasma ionized calcium levels is the principal stimulus for secretion and one of the primary roles of STC in fishes is preventing the development of hypercalcemia. (3) Indeed, fish STC acts on gill, gut and kidney as a calcium and phosphateregulating hormone. (3) (4) (5) Fish and mammals express two stanniocalcin genes, STC1 and STC2. (6) STC1 and STC2 contain Nglycosylation sites, a signal peptide sequence of ~24 amino acids.
Localization of STC1 expression in kidney was examined by in situ hybridization and immunohistochemistry. In rat kidney, the STC1 gene was expressed in the collecting ducts and distal nephron segments. (7) Other reports, however, showed STC1 protein expression in the proximal tubules (proximal straight tubules). (8) Indeed, it has been known that STC1 stimulates phosphate reabsorption in the small intestine and proximal tubules of the kidney. (9, 10) We have previously identified human STC2 gene and observed that the STC2 gene is widely expressed in mice. We also examined the STC2 mRNA expression in hypophosphatemic (Hyp) mice, which is a model of human X-linked hypophosphatemic vitamin D-resistant rickets (XLH) and found it was down-regulated in many organs, and human STC2 decreases phosphate uptake activity and human type IIa sodium-dependent phosphate co-transporter (human NaPi-2a) gene promoter activity in opossum renal proximal tubular cell line (OK cells). (11) Our recent work reported the identification of opossum STC2 gene and observed that its expression and secretion in OK cells were positively and negatively controlled by 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] and parathyroid hormone (PTH). (12) On the other hand, renal STC1 mRNA expression is increased by calcium and 1,25(OH)2D3 in rat and its renal expression are also up-regulated in alpha klotho mutant mice indicating hyperphosphatemia, hypercalcemia and hypervitaminosis D. (13) However, there is no evidence the regulation of STC1 expression by 1,25(OH)2D3 and PTH in renal proximal tubular cells in vitro or whether PTH can affect on its renal expression in vivo.
In the present study, we identified the opossum STC1 cDNA sequence and investigated the regulation of STC1 gene expression by 1,25(OH)2D3 and PTH in renal proximal tubular cells.
Materials and Methods
Cell culture and treatments. Opossum kidney proximal tubular (OK-P) cells were a gift from Dr. Judith A. Cole (Department of Biology, University of Memphis, Memphis, TN). OK-P cells were cultured as described previously. (12) 1,25(OH)2D3 was obtained from Solvay Pharmaceuticals (Marietta, GA). 22-oxacalcitriol (OCT) and 2β-(3-hydroxypropoxy) calcitriol (ED-71) were kindly provided by Chugai Pharmaceutical Co., Ltd. (Tokyo, Japan). Human parathyroid hormone (1-34 fragment) (PTH), 8-bromo-cyclic AMP (8b-cAMP), phorbol 12,13-myristic acetate (PMA) and actinomycin D (ActD) were purchased from Sigma-Aldrich. After reaching 100% confluence, OK-P cells were treated with each reagent at different concentrations and times.
cDNA isolation and DNA sequence analysis. Opossum STC1 gene information was obtained from a BLAST search on the UCSC Genome Bioinformatics website (http://www.genome. ucsc.edu/) with the amino acid sequence of human STC1. On the S basis of this information, oligonucleotide primers specific to the STC1 cDNA sequence were synthesized. The sequences of the upstream and downstream primers were 5'-TCAGAGAATGCT CCACAACTCC-3', and 5'-CTGCCTCGGTTACTCGCTCT-3' respectively. Opossum STC1 cDNA containing an open reading frame was amplified by RT-PCR using total RNA isolated from OK-P cells. The amplification products were purified and subcloned into a pGEM-T Easy vector (Promega), and manually sequenced using the dye terminator cycle sequencing method (Applied Biosystems, Foster City, CA). The cDNA sequences of the opossum STC1 gene have been deposited in GenBank (http:// www.ncbi.nlm.nih.gov) under the accession number AB622590.
Reverse transcription (RT)-PCR and quantitative real-time
RT-PCR. The cells were homogenized in RNA iso plus reagent (Takara Bio Inc., Shiga, Japan). After phenol/chloroform extraction and 2-propanol precipitation, total RNA was dissolved in RNase-free water. First-strand cDNA was synthesized from 2.5 μg of total RNA, primed with oligo (dT) using the MMLVreverse transcriptase (Invitrogen, San Diego, CA). Two μl of the cDNA was then used for subsequent PCR, with 20-30 cycles of amplification, and then PCR products were separated by electrophoresis using 2% agarose gels. For PCR amplification, the primer sequences were: opossum STC1, 5'-CAGAGAATGCTCCAC AACTCCGCC-3' and 5'-CTGCAGAGCAGTGTTGAGGCAT CGG-3'; opossum STC2, 5'-ATGCCCTGAATGGTAAAGCCC ATG-3' and 5'-CACGTAGGGTTCATGCAGTAGCAGATC-3'; opossum β-actin, 5'-CTGACCCTGAAGTACCCCATTGAACA-3' and 5'-CTGGGGTGTTGAAGGTCTCAAACATG-3'; rat STC1, 5'-CCAAGGTCTTCCTTGCCATT-3' and 5'-TGCTGCAAACA T TGAGCTTG-3'; rat β-actin, 5'-GTCCCAGTATGCCTCTGG TCGTAC-3' and 5'-CCACGCTCGGTCAGGATCTTCATG-3'. RT-PCR was performed with a PCR system (ASTEC, Fukuoka, Japan) using Go Taq Master Mix (Promega, Madison, WI). Realtime PCR analysis was performed using the LightCycler TM (Roche Diagnostics, Tokyo, Japan). The prepared first-strand cDNA was PCR amplified using Light Cycler fast start DNA master SYBR Premix Ex Taq (Takara Bio Inc., Shiga, Japan) in a 20 μl reaction volume, with 4 pmol of each primer. β-actin was used as the internal control. The amplification program was 95°C for 10 s followed by 50 cycles of 95°C for 10 s, 60°C for 15 s, and 72°C for 15 s. Amplified products were then analyzed using a melting curve, which confirmed the presence of a single PCR product in all reaction (apart from negative control). The products were quantified by fit-point analysis, and results for STC1 and STC2 were normalized to those of β-actin.
Experimental animals. Eight-week-old Sprague-Dawley (SD) male rats were purchased from Japan SLC, Inc. (Shizuoka, Japan). Rats were maintained with 12 h light: 12 h darkness cycles with free access to regular rat chow and water under pathogen-free conditions. The breeding and handling of all animals in these experiments was approved by the Animal Experimentation Committee of the University of Tokushima. Rats were fed a lowphosphate diet (0.02% Pi and 0.6% Ca) for 3 days. (14) Then, human-PTH (1-34) (10 μg/100 g body weight) was injected into the jugular vein. After treatment for 0.5 h, the rats were sacrificed.
Western blot analysis. The whole kidney was homogenized in lysis buffer containing 1% Triton X-100, 1% Na deoxycholate, 0.1% SDS, 10 mM Tris-HCl, pH 8.0, 140 mM NaCl. Protein samples were electrophoresed on 12% SDS/PAGE and transferred to PVDF membrane (Immobilon-P, Millipore). The membrane were treated with diluted anti-STC1 antibody (1:1000) (Santa Cruz) and anti-NaPi-2a antibody (1:5000). Mouse anti-actin monoclonal antibody (Sigma) was used as an internal control. Horseradish peroxidase (HRP)-labeled anti-IgG (Bio-Rad) was utilized as the secondary antibody, and signal were detected using the ECL plus system (GE Healthcare, Buckinghamshire, UK).
Statistical analysis. Data are expressed as means ± SD. Statistical significance between groups was determined using ANOVA followed by post hoc testing using Fisher's protected least significant difference (PLSD). p<0.05 was considered to be significant.
Results

Identification of opossum STC1 amino acid sequences.
We first identified opossum STC1 cDNA using information obtained from the UCSC genome database website. The opossum STC1, human STC1 sequences and opossum STC2 were then aligned. We assessed STC1 in opossum and human, and STC1 and STC2 in opossum. The results presented in Fig. 1A showed that opossum STC1 amino acid sequence had 83.7% homology with human STC1, and conserved 11 cysteine residues and a putative N-linked glycosylation site as well as human STC1. We next compared the amino acid sequence of opossum STC1 with that of opossum STC2. Although it was seen at 10 conserved cysteine residues and a putative N-linked glycosylation site, it had only 35.3% homology.
Regulation of STC1 mRNA expressions by 1,25(OH)2D3 in opossum kidney cells. In our previous study, we identified opossum STC2 and demonstrated the STC2 gene expression in OK-P cells was up-regulated by 1,25(OH)2D3 in transcriptional control, but PTH and PMA as the PKC activator down-regulated its expression. (12) In this experiment, we investigated about the regulation of STC1 gene by 1,25(OH)2D3, PTH and PMA, and compared with the STC2 gene expression. Using Reverse Transcript-PCR and Real time PCR, we now investigated whether the STC1 mRNA expression in OK-P cells is controlled by 1,25(OH)2D3 and PTH. As shown in Fig. 2A, 1,25 (OH)2D3 increased both the mRNA levels of STC1 and STC2 in OK-P cells. Real-time quantitative PCR analyses revealed that 1,25(OH)2D3 increases the STC1 mRNA levels in OK-P cells in a dose-and time-dependent manner ( Fig. 2 B and C) . However, the efficacy of 1,25(OH)2D3 for the STC1 gene was 10-folds less than STC2 gene (Fig. 2B) . The up-regulation of STC1 gene expression by 1,25(OH)2D3 was evident at 1 h and reached its peak at 6 h, with a 7-folds increase at the time (Fig. 2C) . In addition, we found the STC1 mRNA expression is also up-regulated by OCT and ED-71, which is 1,25(OH)2D3 analogs (Fig. 2D) .
Up-regulation of STC1 mRNA expression by PTH in vitro and in vivo. We then determined whether PTH affects on the STC1 mRNA expression in OK-P cells. 6 h treatment with PTH in OK-P cells significantly increased the levels of STC1 mRNA, but decreased that of STC2 mRNA (Fig. 3A) . The opposite effects of PTH on the mRNA expression of STC1 and STC2 were observed in time-dependent manners (Fig. 3B ). In addition, we confirmed the effects of PTH on renal STC1 expression in vivo. As shown in Fig. 3C , the renal mRNA levels of STC1 was significantly increased at both periods of 0.5 h and 3 h after PTH injection. It has been well-known that the renal NaPi-2a expression is downregulated by PTH. (15) (16) (17) Therefore, we also investigated the renal NaPi-2a expression as a good PTH target gene. Western blot analysis showed that PTH increased the protein levels of STC1, but decreased that of NaPi-2a (Fig. 3D) .
PMA stimulates STC1 mRNA expression in OK-P cells.
To gain further understanding of the mechanisms involved in the regulation of the STC1 gene by PTH, we observed that the effects of 8-brommo-cyclic AMP as a PKA activator and PMA as a PKC activator on the STC1 mRNA expression in OK-P cells. As showed in Fig. 4A , the STC1 mRNA levels were significantly increased by PMA, but not 8-brommo-cyclic AMP. Dose-and timedependent experiments showed that PMA oppositely controlled the mRNA levels of STC1 and STC2 gene in OK-P cells as well as PTH (Fig. 4 B and C) . Furthermore, PMA and 1,25(OH)2D3 additively increased the STC1 mRNA levels, however, PMA completely suppressed 1,25(OH)2D3-induced STC2 mRNA expression (Fig. 4D) .
Stabilization of STC1 mRNA by 1,25(OH)2D3 and PMA in
OK-P cells. Our previous study using ActD indicated that the opossum STC2 gene expression was up-regulated by 1,25(OH)2D3 at transcriptional levels. (12) Surprisingly, pretreatment with ActD did not suppressed 1,25(OH)2D3 or PMA-induced STC1 mRNA expression in the OK-P cells (Fig. 5 A and B) . To determine if the elevation in STC1 mRNA was associated with enhanced mRNA stability, we performed a standard mRNA decay assay. ActD was added to OK-P cells to prevent any new gene transcription, and STC1 mRNA levels were monitored over the following 12-h period in cells treated with ActD only and in cells treated with ActD plus either 1,25(OH)2D3 or PMA. As shown in Fig. 5 C and D, the half-life of STC1 mRNA in ActD-treated cells was about 2.5 h; 1,25(OH)2D3 and PMA treatments increased the half-lifẽ 2.5-fold (to 12 h) and ~3-fold (6 h), respectively. These results indicate that both 1,25(OH)2D3 and PMA induce STC1 mRNA levels primarily by inhibiting its decay.
Discussion
The present study characterized a cDNA that encodes STC1 in opossum and investigated the effects of 1,25(OH)2D3 and PTH on STC1 mRNA levels in renal proximal tubular cells. Fig. 1A indicated that the opossum STC1 amino acid sequence have showed 83.7% homology with human STC1. More importantly, the deduced amino acid sequence of opossum STC1 has features perfectly conserved with the 11 cysteine residues and the unique N-linked glycosylation site of human STC1. (18) (19) (20) Although opossum STC1 showed a lower sequence identity of 35.3% sequence homology with opossum STC2, we found that the position of key cysteine residues and the N-linked glycosylation site are strictly conserved between opossum STC1 and opossum STC2 (Fig. 1B) . These results consisted with our previous report for the identification of human STC2 cDNA sequence and the homology with human STC1. (11) It has been assumed that STC1 and STC2 have overlapping functions because of their similarities in primary amino acid sequence. (20, 21) However, human STC1 inhibits calcium transport activity on gill in fish, but not human STC2. (3, 22) Furthermore, high-affinity STC1-binding are observed on both the plasma membrane and mitochondria in nephron epitherial cells and liver hepatocytes, but, STC2 is unable or weakly capable of displacing STC1 in receptor binding assays. (23) (24) (25) (26) (27) (28) These evidences strongly suggest that the biological roles of STC1 in mammals may differ from those of STC2.
We have previously reported STC2 expression is positively and negatively regulated by 1,25(OH)2D3 and PTH in the renal proximal tubular cells. (12) RT-PCR and real-time PCR analysis indicated that both STC1 and STC2 mRNA expressions were increased by 1,25(OH)2D3. These results could support previous in vivo experiments that 1,25(OH)2D3 could increase the STC1 Fig. 1 . Identification of opossum STC1 amino acid sequences. Opossum STC1 cDNA was cloned by RT-PCR analysis using information obtained from the UCSC genome database website. The amino acid sequences of opossum STC1 were then aligned with (A) human STC1 and (B) opossum STC2. The underlined sequence indicated the predicted signal peptide region. The N-glycosylation site is shown as a closed triangle. The conserved cysteine residues are indicated by black dots. Fig. 2 . Effects of 1,25(OH)2D3 on the STC1 mRNA expressions in OK-P cells. When OK-P cells reached confluence, the cells were treated with the control (final concentration of ethanol, 0.1%) or (A) 100 nM 1,25D3 for 6 h, or multiple concentrations of (B) 1,25D3 for 6 h, or (C) 100 nM 1,25D3 for time course study. (D) The cells were also incubated with the control, 100 nM 1,25D3, OCT or ED-71 for 6 h. RNA was extracted from cells at the indicated time points, and RT-PCR or real-time RT-PCR was performed to evaluate STC1 and STC2 expression. Results were normalized to the mRNA expression level of β-actin. The data are represented as the means ± SD (n = 3). *p<0.05, **p<0.001 compared with control. Fig. 3 . Effects of PTH on the STC1 expression in OK-P cells and rat kidney. (A, B) OK-P cells were incubated with the control (final concentration of ethanol, 0.1%) and 100 nM PTH for 6 h or different periods of time. The mRNA levels of STC1 and STC2 in OK-P cells were determined by RT-PCR and real-time PCR analysis. (C, D) SD male rats were fed a low-phosphate diet for 3 days, low-phosphate diet contained 0.02% Pi and 0.6% Ca, and then 10 μg human PTH (1-34)/100 g body weight was injected into the jugular vein. After treatment for 0.5 h and 3 h, the mRNA expression levels of STC1 in kidney were quantified by real-time PCR. Results were normalized to the mRNA expression level of β-actin. Values are means ± SD (n = 3-5). *p<0.05, **p<0.001 compared with control. (D) The renal protein levels of STC1 and NaPi-2a were measured by western blot analysis. β-actin was used as an internal control. expression in kidney. (13, 29, 30) Interestingly, we also found that PTH stimulated the STC1 mRNA expression in OK-P cells and rat kidney. In contrast, the STC2 gene expression in OK-P cells was down-regulated by PTH as well as our previous experiment. (12) Furthermore, we confirmed the decrease of NaPi-2a protein levels at 0.5 h after PTH treatment (Fig. 3D) . Although hyperphos- Fig. 4 . Effects of PMA on the STC1mRNA expression in OK-P cells. (A) OK-P cells were treated with the control or 100 nM 8-bro-cAMP, a specific PKA activator, or PMA, a specific PKC activator for 3 h. OK-P cells were also treated with (B) the different doses of PMA for 3 h, or (C) 100 nM PMA for time course study, or (D) 100 nM PMA for 3 h or 100 nM 1,25(OH)2D3 for 6 h. After treatment with 1,25(OH)2D3 and/or PMA, the cells were harvested and total RNA was extracted. The mRNA levels of STC1 and STC2 were determined by real-time PCR analysis. Results are expressed as the means ± SD (n = 3). *p<0.05, **p<0.01 compared with vehicle.
phatemia or hypercalcemia or calcitriol increases the STC1 gene expression, (13, 29, 30) we characterized that 1,25(OH)2D3 and PTH directly up-regulates the STC1 gene in real proximal tubular cells. Because 1,25(OH)2D3 and PTH have been well-known as major hormones regulating calcium and phosphate homeostasis in kidney and intestine, (31) therefore, our finding in this study about the up-regulation of STC1 gene by 1,25(OH)2D3 and PTH may be able to understand the physiological significance of STC1 as a calcium/phosphate-regulating hormone.
PTH binds to the PTH/PTH-related protein receptor on kidney cells and generates multiple second messengers including cAMP (which activates PKA), diacylglycerol (which activates PKC), inositol trisphosphate, and increased levels of intracellular calcium. (32, 33) To determine the stimulatory mechanism of PTH on STC1 expression, we examined the signaling pathway of PKA and PKC using 8-bromo-cAMP and PMA, respectively. As shown in Fig. 4 B and C, PMA increased the STC1 mRNA levels, but decreased the STC2 mRNA levels in dose-and time-dependent manners. These data suggest that PTH up-regulates the STC1 expression mediated through the PKC activation in renal proximal tubular cells. Recently study has been reported that the STC1 expression in kidney is induced by hypertonicity such as NaCl or mannitol, and the activation of PKC, phospholipase C (PLC) and inositol 1,4,5-trisphosphate (IP3) is involved in the hypertonicitydependent STC1 gene regulation. (34) More interestingly, they showed that the hypertonicity increased the STC1 mRNA levels in the cortex, but not in the inner medulla. (34) In fact, we also observed that after 3 h treatment with PTH in rat significantly increased the mRNA levels of STC1 in the cortex kidney but not in the medullar kidney (data not shown).
We finally examined whether or not the stability of the STC1 mRNA could be altered by treatment with 1,25(OH)2D3 and PMA. In Fig. 5 A and B, surprisingly there was no observation the suppression of the 1,25(OH)2D3 and PMA induced STC1 mRNA expression by ActD. Moreover, both of 1,25(OH)2D3 and PMA increased the stability of STC1 mRNA in the presence of ActD (Fig. 5 C and D) . It has been reported that 1,25(OH)2D3 stabilizes the osteocalcin mRNA in ROS 17/2.8 cells and c-fms mRNA in HL-60 cells, (35, 36) 5-lipoxygenase mRNA in the human monocytic cell line Mono Mac 6. (37) In this study, we can not explain how 1,25(OH)2D3 increases the STC1 mRNA in OK-P cells, however, there is an evidence that the stimulatory effect of Ca 2+ on STC gene expression is due to mRNA stabilization in primary cultured trout corpuscles of Stannius cells. We now believe that the analysis of not only the promoter region but also the 3'-untranslated region of the STC1 gene is necessary to understand the molecular mechanism of STC1 gene regulation.
Importantly, the genome-wide association studies in the chronic kidney disease (CKD) patients has been identified STC1 and NaPi-2a (SLC34A1) as one of susceptibility loci in association with estimated glomerular filtration rate. (38, 39) Recent study has also reported that STC1 has anti-inflammatory and renal protective actions in a model of anti-glomerular basement membrane glomerulonephritis. (40) Thus the suitable control of STC1 gene expression in kidney might be able to contribute provide both prevention and treatment for CKD.
In summary, we have identified a novel STC1 amino acid sequence in opossum and demonstrated that STC1 gene is directly up-regulation by 1,25(OH)2D3 and PTH in renal proximal tubular OK-P cells, and PTH can increase its renal expression in vivo. Furthermore, we have shown that 1,25(OH)2D3 and PMA regulates the STC1 gene in post-transcriptional levels.
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